Stockscreener 앱 받기
6.01
0.00%
0.00
시간 외 거래:
5.93
-0.08
-1.33%
전일 마감가:
$6.01
열려 있는:
$5.96
하루 거래량:
99,466
Relative Volume:
0.28
시가총액:
$299.53M
수익:
$13.55M
순이익/손실:
$-25.32M
주가수익비율:
-11.09
EPS:
-0.542
순현금흐름:
-
1주 성능:
-6.97%
1개월 성능:
-12.52%
6개월 성능:
+23.92%
1년 성능:
+0.00%
1일 변동 폭
$5.68
$6.05
1주일 범위
$5.36
$6.60
52주 변동 폭
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
명칭
Capsovision Inc
전화
(408) 370-4790
주소
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.01 | 299.53M | 13.55M | -25.32M | 0 | -0.542 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-28 | 개시 | Roth Capital | Buy |
| 2025-07-28 | 개시 | The Benchmark Company | Speculative Buy |
Capsovision Inc 주식(CV)의 최신 뉴스
Capsovision Incfiles prospectus for resale of 2,867,089 common shares by selling stockholdersSEC filing - marketscreener.com
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Sahm
Ching Hang Shen Net Worth (2026) - GuruFocus
CapsoVision (CV) ownership: Shen Ching Hang holds 6.40M shares, Star One indirect - Stock Titan
CapsoVision, Inc. (NASDAQ:CV) Sees Significant Increase in Short Interest - MarketBeat
CapsoVision Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsCV - GuruFocus
CapsoVision (CV) Schedule 13G/A: CID group, Altenza and individuals report ≤5% holdings - Stock Titan
Earnings Preview: CapsoVision to Report Financial Results Post-market on March 26 - Moomoo
Major CapsoVision (CV) holder Shen Ching Hang reports large direct and indirect stake - Stock Titan
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Grows By 35.2% - MarketBeat
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline By Investing.com - Investing.com Australia
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline - Investing.com Australia
CapsoVision (NASDAQ:CV) Price Target Lowered to $10.00 at Benchmark - MarketBeat
CapsoVision 2025 Financial Performance Review - AlphaStreet
CapsoVision revenue up 13% to USD 3.9M in Q4 2025 - Medical Buyer
CapsoVision’s CapsoCam: 360° Panoramic AI-Powered Capsule Endoscopy Solution Expanding Global GI Diagnostics Market 2324323344 - Minichart
Large CapsoVision (CV) holder discloses direct and trust share stakes - Stock Titan
CapsoVision Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips - Investing.com Australia
CapsoVision Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa
CapsoVision Inc reports results for the quarter ended September 30Earnings Summary - TradingView
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
CV: AI-powered capsule endoscopy drives growth and innovation in noninvasive GI screening - TradingView
CapsoVision 10-K: Revenue $13.6M, EPS $(1.03) — Annual Results - TradingView
CapsoVision (NASDAQ: CV) flags going concern while advancing AI colon capsule - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
CapsoVision Faces Deadline to Turn Capital Into Profit Before Runway Collapses - Bitget
CapsoVision (NASDAQ: CV) grows 2025 revenue 15% as net loss widens - Stock Titan
CapsoVision, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
CapsoVision Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening - MarketBeat
CapsoVision price target raised to $11 from $7 at Roth Capital - tipranks.com
CapsoVision (CV) director receives 4,045 RSU equity award - Stock Titan
CapsoVision (CV) awards 4,045 RSUs to board director - Stock Titan
CapsoVision (CV) director receives 4,045 RSU grant as board compensation - Stock Titan
CapsoVision (CV) director receives 4,045 RSUs vesting through 2026 - Stock Titan
CapsoVision (CV) awards 4,045 restricted stock units to director - stocktitan.net
[Form 4] CapsoVision, Inc Insider Trading Activity - Stock Titan
CV: AI-powered capsule endoscopy targets multi-cancer detection with global expansion and strong funding - TradingView
CV: CapsoVision advances AI-powered capsule endoscopy with strong pipeline and global expansion - TradingView
CapsoVision Closes $14 Mln Private Placement; Reports Preliminary Q4 Revenue Of $3.9 Mln - RTTNews
CapsoVision’s Strategic Moves Spike Stock as Market Anticipates Growth - timothysykes.com
CapsoVision Surges 13% on Closing $14M Private Placement - StocksToTrade
CapsoVision Closes $14 Million Private Placement and Reports Preliminary 2025 Financial Results - Minichart
CapsoVision closes $14 million private placement financing By Investing.com - Investing.com Australia
CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | H6U | US1409351079 - marketscreener.com
CapsoVision Raises Capital and Refocuses Colon Capsule Strategy - TipRanks
CapsoVision closes $14 million private placement financing - Investing.com
CapsoVision Raises ~$14 Million in Private Placement, Selling 2.87M Shares at $4.883 - tradingview.com
Capsovision Inc (CV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):